Tools

LEADER 04445cam a22005537a 4500

001 ssj0000746505;

003 WaSeSS;

005 20230912080512.0;

006 m d ;

007 cr n ;

008 130212s2012 dcu sb 100 0 eng d;

010 a| 2012289480;

020 a| 9780309261166 (pbk.);

020 a| 0309261163 (pbk.);

035 a| (WaSeSS)ssj0000746505;

042 a| lccopycat;

049 a| EREEa| NEHH;

050 00 a| RM302b| .I58 2012;

082 00 a| 615.1/92| 23;

110 2 a| Institute of Medicine (U.S.).b| Forum on Drug Discovery, Development, and Translation.=| ^A1035701;

245 10 a| Maximizing the impact of the Cures Acceleration Networkh| [electronic resource] :b| accelerating the development of new drugs and diagnostics : workshop summary /c| Steve Olson and Anne B. Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies.;

246 30 a| Accelerating the development of new drugs and diagnostics;

260 a| Washington, D.C. :b| National Academies Press,;

300 a| xvi, 115 p. ;c| 23 cm.;

504 a| Includes bibliographical references (p. 71).;

505 0 a| Introduction [The history and goals of CAN (Cures Acceleration Network)] -- Approaches to accelerating translational science -- Application of matching authority -- Application of flexible research authority -- Situating CAN within the drug development ecosystem -- Final reflections on ways to maximize the goals of CAN.;

506 a| Available only to authorized users.;

520 a| Advances in technologies and knowledge are creating new avenues for research and opportunities for the discovery and clinical development of innovative therapies and diagnostics. However, despite these opportunities, only a small fraction of investigational products are successfully developed into cures and therapies that can be accessed by patients. One response to the ever-widening gap between the number and promise of basic scientific discoveries and the translation of those discoveries into therapies is a renewed emphasis on collaborative approaches among federal agencies, academia, and industry, all directed at the advancement of the drug development enterprise. The newly developed Cures Acceleration Network (CAN)-a part of the National Center for Advancing Translational Sciences (NCATS) within the National Institutes of Health (NIH)-has the potential to catalyze widespread changes in NCATS, NIH, and the drug development ecosystem in general. On June 4-5, 2012, the IOM Forum on Drug Discovery, Development, and Translation held, at the request of NCATS, a workshop-bringing together members of federal government agencies, the private sector, academia, and advocacy groups-to explore options and opportunities in the implementation of CAN. Accelerating the Development of New Drugs and Diagnostics: Maximizing the Impact of the Cures Acceleration Network: Workshop Summary summarizes the workshop."--Publisher's description.;

530 a| Also available online.;

538 a| Mode of access: World Wide Web;

650 0 a| Drug monitoring.=| ^A404118;

650 0 a| Drug developmentz| United States.=| ^A443888;

650 0 a| Drugsz| United Statesx| Design.=| ^A640;

650 0 a| Pharmaceutical industryz| United Statesx| Quality control.=| ^A638;

655 0 a| Electronic books.=| ^A491897;

700 1 a| Olson, Steve,d| 1956-=| ^A148058;

700 1 a| Claiborne, Anne B.=| ^A1108281;

856 40 z| Full text available from Ebook Central - Academic Completeu| https://ebookcentral.proquest.com/lib/eastcarolina/detail.action?docID=3379066;

947 a| (OCoLC)ocn811963294;

949 a| CLICK ON WEB ADDRESSw| ASISh| JOYNER188;

949 a| CLICK ON WEB ADDRESSw| ASISh| HSL77;

949 a| CLICK ON WEB ADDRESSw| ASISh| JMUSIC60;

596 a| 1 3 4;

998 a| 3957731;

999 a| CLICK ON WEB ADDRESSw| ASISc| 1i| 3957731-1001l| JNETm| JOYNERr| Ys| Yt| JNESSBKu| 1/1/2016x| EBOOKz| JERESOURCE;

999 a| CLICK ON WEB ADDRESSw| ASISc| 1i| 3957731-2001l| HSLELECm| HSLr| Ys| Yt| HEBKu| 1/1/2016x| EBOOKz| HERESOURCE;

999 a| CLICK ON WEB ADDRESSw| ASISc| 1i| 3957731-3001l| MNETm| JMUSICr| Ys| Yt| MNESSBKu| 1/1/2016x| EBOOKz| JERESOURCE;

Maximizing the impact of the Cures Acceleration Network accelerating the development of new drugs and diagnostics : workshop summary / Steve Olson and Anne B. Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies.

Author/creator	Institute of Medicine (U.S.).
Other author	Olson, Steve, 1956-
Other author	Claiborne, Anne B.
Format	Electronic
Publication Info	Washington, D.C. : National Academies Press,
Description	xvi, 115 p. ; 23 cm.
Supplemental Content	Full text available from Ebook Central - Academic Complete
Subjects	United States. Institutes of Health. National Center for Advancing Translational Sciences. Cures Acceleration Network. Drug monitoring. Drug development--United States. Drugs--United States. --Design. Pharmaceutical industry--United States. --Quality control.

Portion of title	Accelerating the development of new drugs and diagnostics
Contents	Introduction [The history and goals of CAN (Cures Acceleration Network)] -- Approaches to accelerating translational science -- Application of matching authority -- Application of flexible research authority -- Situating CAN within the drug development ecosystem -- Final reflections on ways to maximize the goals of CAN.
Abstract	Advances in technologies and knowledge are creating new avenues for research and opportunities for the discovery and clinical development of innovative therapies and diagnostics. However, despite these opportunities, only a small fraction of investigational products are successfully developed into cures and therapies that can be accessed by patients. One response to the ever-widening gap between the number and promise of basic scientific discoveries and the translation of those discoveries into therapies is a renewed emphasis on collaborative approaches among federal agencies, academia, and industry, all directed at the advancement of the drug development enterprise. The newly developed Cures Acceleration Network (CAN)-a part of the National Center for Advancing Translational Sciences (NCATS) within the National Institutes of Health (NIH)-has the potential to catalyze widespread changes in NCATS, NIH, and the drug development ecosystem in general. On June 4-5, 2012, the IOM Forum on Drug Discovery, Development, and Translation held, at the request of NCATS, a workshop-bringing together members of federal government agencies, the private sector, academia, and advocacy groups-to explore options and opportunities in the implementation of CAN. Accelerating the Development of New Drugs and Diagnostics: Maximizing the Impact of the Cures Acceleration Network: Workshop Summary summarizes the workshop."--Publisher's description.
Bibliography note	Includes bibliographical references (p. 71).
Access restriction	Available only to authorized users.
Other forms	Also available online.
Technical details	Mode of access: World Wide Web
Genre/form	Electronic books.
LCCN	2012289480
ISBN	9780309261166 (pbk.)
ISBN	0309261163 (pbk.)

Availability

Library	Location	Call Number	Status	Item Actions
	Electronic Resources	Access Content Online	✔ Available

Click here for more information about this title

Availability